碳离子再照射治疗复发头颈癌的单中心经验
本研究回顾性分析229例2010-2017年接受碳离子再照射(CIR)的复发头颈癌患者,评估无进展生存、总生存、失败模式和毒性。中位局部无进展生存24.2个月,中位总生存26.1个月,≥3级晚期毒性发生率为14.5%。CIR是局部复发头颈癌可行、有效且毒性可接受的治疗选择。
要点
- 复发头颈癌CIR后中位局部无进展生存24.2个月,中位总生存26.1个月。
- ≥3级晚期毒性18例(14.5%),包括中枢神经系统坏死、视神经损伤等。
- CIR可作为特定患者手术挽救和姑息化疗的有价值替代方案。
核心结论
- 在局部复发头颈癌患者中,CIR是可行、有效且毒性可接受的治疗,局部控制良好。
- CIR是特定患者手术挽救和姑息化疗的有价值替代方案。
研究设计与样本
- 回顾性单中心研究,纳入229例2010-2017年间接受CIR的复发头颈癌患者。
- 评估无进展生存、总生存、失败模式和毒性。
主要发现
- 原发肿瘤中54.1%为腺样囊性癌,26.2%为鳞状细胞癌,8.3%为腺癌,11.4%为其他类型。
- 中位放疗间隔3.9年(范围0.3-46.5年),中位剂量51 Gy(RBE;范围30-66 Gy [RBE]),分次3 Gy(RBE)。
- CIR后中位累积终生剂量132.8 Gy(范围88.8-155.0 Gy)。
- 中位局部无进展生存24.2个月(95%CI 19.4-29.0个月),中位总生存26.1个月(95%CI 21.9-30.3个月)。
- ≥3级晚期毒性18例(14.5%),包括中枢神经系统坏死4/3级1例(0.8%)/5例(4.0%)、视神经损伤4/3级2例(1.6%)/2例(1.6%)、听力受损3级5例(4.0%)、骨坏死3级1例(0.8%)、颈动脉破裂4级1例(0.8%)。
临床怎么用
- 对于局部复发头颈癌,CIR可作为手术挽救和姑息化疗的替代选择,尤其适用于特定患者。
局限性
- 回顾性单中心研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to assess the feasibility of carbon ion reirradiation (CIR) for recurrent head and neck cancer (HNC). METHODS AND MATERIALS: This retrospective study included 229 patients with recurrent HNC who were treated with CIR between 2010 and 2017. We assessed progression-free survival, overall survival, pattern of failure, and toxicity. Of the primary tumors, 54.1% were adenoid cystic carcinomas, 26.2% were squamous cell carcinomas, 8.3% were adenocarcinomas, and 11.4% were other tumor entities. RESULTS: The median radiation therapy interval was 3.9 years (range, 0.3-46.5 years), and patients received a median dose of 51 Gy (relative biological effectiveness [RBE]; range, 30-66 Gy [RBE]) in 3 Gy (RBE) fractions. The median cumulative lifetime dose after CIR was 132.8 Gy (range, 88.8-155.0 Gy). The median local progression-free survival after CIR was 24.2 months (95% confidence interval, 19.4-29.0 months), and the median overall survival was 26.1 months (95% confidence interval, 21.9-30.3 months). Serious acute toxicity (grade ≥3) after CIR included laryngeal edema, grade 4 (n = 2; 0.9%); dysphagia, grade 3 (n = 3; 1.3%); fistula, grade 3 (n = 1; 0.4%); and impaired hearing, grade 3 (n = 1; 0.4%). Late toxicities of grades 3 or higher (n = 18; 14.5%) included central nervous system necrosis, grades 4/3 (n = 1; 0.8%/n = 5; 4.0%); optic nerve disorder, grades 4/3 (n = 2; 1.6%/n = 2; 1.6%); impaired hearing, grade 3 (n = 5; 4.0%), osteonecrosis, grade 3 (n = 1; 0.8%); and carotid blowout, grade 4 (n = 1; 0.8%). CONCLUSIONS: In patients with locally recurrent HNC, CIR was a feasible, effective treatment with acceptable toxicity and good local control. Thus, CIR represented a valuable alternative to surgical salvage and palliative chemotherapy in selected patients.
引用
- Held T, Windisch P, Akbaba S, et al. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience. Int J Radiat Oncol Biol Phys. 2019. PMID: 31349059. doi:10.1016/j.ijrobp.2019.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。